Capstone Therapeutics Corp

Capstone Therapeutics Corporation is a biotechnology company committed to developing a pipeline of novel therapeutic peptides aimed at helping patients with under-served medical conditions. The company is focused on development and commercialization of two product platforms: AZX100 and Chrysalin(r) (rusalatide acetate or TP508). AZX100 is a novel synthetic 24-amino acid peptide, one of a new...